Essayer OR - Gratuit

Making sure APIs made & controlled in consistent way

Ingredients South Asia

|

December 1-15, 2025

THERE are a lot of rules, methods, and quality systems that make sure active pharmaceutical ingredients (APIs) are safe, effective, and meet international pharmacopeial and regulatory standards.

- N SUNANDA

Making sure APIs made & controlled in consistent way

These rules are called Current Good Manufacturing Practices (cGMP). Because APIs have a direct impact on the safety and effectiveness of finished medical products given to patients, they need to be closely monitored for quality. APIs are the main active ingredients in pharmaceutical drugs.

An Overview of cGMP and Why It's Important in API Manufacturing:

The idea of "current" is part of cGMP, a new way of thinking about Good Manufacturing Practices (GMP) that focusses on using new technologies, scientific discoveries, and quality risk management methods. The main goal of cGMP is to set up a system that makes sure APIs are made and controlled in a consistent way that meets certain quality standards. This system also lowers the risks of contamination, mix-ups, and deviations during the manufacturing process.

Manufacturing under cGMP conditions covers every important step, from getting and handling raw materials and starting materials to synthesis, isolation, purification, and physical processing, as well as packing, labelling, storing, and shipping. It also includes intermediates and in-process quality control to make sure that the quality and safety profiles stay the same at all times.

Following cGMP makes sure that APIs meet the set standards for identification, purity, strength, and quality. All of these things are important for making sure that patients are safe and that the treatment works. The US Food and Drug Administration (FDA), the European Medicines Agency (EMA), the World Health Organization (WHO), and the International Council for Harmonisation (ICH) have all made cGMP requirements official through guidance documents like ICH Q7, the FDA Code of Federal Regulations (21 CFR parts), and WHO GMP guidelines.

Important Parts of cGMP for APIs

1. Quality Management System (QMS)

PLUS D'HISTOIRES DE Ingredients South Asia

Ingredients South Asia

Ingredients South Asia

With 50.40% in 2024, captive APIs led the market

PHARMACEUTICAL ingredients are mainly divided into two parts i.e. active and inactive pharmaceutical ingredients.

time to read

4 mins

December 1-15, 2025

Ingredients South Asia

Ingredients South Asia

As mfg evolves, quality control must adapt

IN the pharmaceutical industry, the quality of raw materials especially active pharmaceutical ingredients (APIs) and excipients is what makes medicines safe, effective and trustworthy.

time to read

4 mins

December 1-15, 2025

Ingredients South Asia

Ingredients South Asia

The unspoken designers of effective drug treatment

Medicine has been related to the active pharmaceutical ingredient (API), the chemical compound that produces therapeutic effect. However, the path between the discovery in a laboratory and a pill in your hand cannot be fully made without excipients.

time to read

5 mins

December 1-15, 2025

Ingredients South Asia

Ingredients South Asia

Adv fermentation can convert agri waste into cosmetic actives

The natural cosmetics industry is growing at an unprecedented rate. The global market is expected to grow from $52.4 billion in 2025 to $95.7 billion by 2035, which is a strong compound annual growth rate of 5.7%.

time to read

4 mins

December 1-15, 2025

Ingredients South Asia

India's cold storage leap: Driving food security

INDIA'S agriculture sector, with a GDP of $262 billion, showcases remarkable resilience, being minimally dependent on imports.

time to read

4 mins

December 1-15, 2025

Ingredients South Asia

Transforming India's ingredient mfg landscape

COME December 19-21, 2025, the pharmaceutical world will descend on Bengaluru, not just for another congress, but for a high-stakes convergence of technology, education, and industry - the 74th Indian Pharmaceutical Congress (IPC).

time to read

4 mins

December 1-15, 2025

Ingredients South Asia

in-cos attracts celebs at star-studded edition

IN-cosmetics Asia delivered its most influential edition to date. This year's event attracted a star-studded mix of high-profile industry leaders, Csuite executives, celebrity guests, Asian A-listers, beauty entrepreneurs and heads of some of the world's best-known cosmetics houses.

time to read

3 mins

December 1-15, 2025

Ingredients South Asia

Ingredients South Asia

CMOs optimise supply chain & reduce costs

PHARMACEUTICAL contract manufacturing is when pharmaceutical companies outsource drug production to specialised third-party manufacturers.

time to read

4 mins

December 1-15, 2025

Ingredients South Asia

Ingredients South Asia

Modular and compact designs are gaining traction

INDIA'S pharmaceutical sector is often referred to as the “pharmacy of the world.” Behind this reputation lies not only drug formulation expertise but also the robust ecosystem of pharma processing machinery manufacturers.

time to read

4 mins

December 1-15, 2025

Ingredients South Asia

DGFT resolves concern related to redemption of AAS

IN a significant relief for pharmaceutical exporters, the Directorate General of Foreign Trade (DGFT) has issued a clarification resolving a long-standing concern related to the redemption of Advance Authorisations (AAS) impacted by the erstwhile Rule 96(10) of the CGST Rules-2017.

time to read

2 mins

December 1-15, 2025

Listen

Translate

Share

-
+

Change font size